AB Science S.A.
ABSCF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 0.6% | -8.6% | 7.3% | – |
| Cost of Goods Sold | $0 | -$0 | $0 | $0 |
| Gross Profit | $0 | $1 | $0 | $0 |
| % Margin | 29.3% | 152.5% | 83.4% | 68.6% |
| R&D Expenses | $3 | $0 | $3 | $5 |
| G&A Expenses | $1 | $2 | $1 | $1 |
| SG&A Expenses | $1 | $2 | $1 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1 | $1 | $0 | -$1 |
| Operating Expenses | $3 | $3 | $4 | $5 |
| Operating Income | -$3 | -$3 | -$4 | -$5 |
| % Margin | -529.7% | -488.5% | -639.6% | -877.2% |
| Other Income/Exp. Net | -$2 | -$1 | -$1 | $3 |
| Pre-Tax Income | -$5 | -$3 | -$4 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$3 | -$4 | -$2 |
| % Margin | -1,005.2% | -656.6% | -798% | -301.5% |
| EPS | -0.089 | -0.064 | -0.087 | -0.03 |
| % Growth | -39.2% | 26.2% | -184.5% | – |
| EPS Diluted | -0.09 | -0.064 | -0.087 | -0.03 |
| Weighted Avg Shares Out | 58 | 53 | 52 | 51 |
| Weighted Avg Shares Out Dil | 58 | 53 | 52 | 51 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $0 | -$0 |
| EBITDA | -$3 | -$2 | -$3 | -$5 |
| % Margin | -490.5% | -379.3% | -604.1% | -971.8% |